CDLX - CIK 0001666071
Cardlytics, Inc. (CDLX) reported net income of -$104.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$104.00M | +45.0% |
| FY 2024 | -$189.00M | -40.0% |
| FY 2023 | -$135.00M | +71.0% |
| FY 2022 | -$465.26M | -261.9% |
| FY 2021 | -$128.56M | -132.0% |
| FY 2020 | -$55.42M | -223.3% |
| FY 2019 | -$17.14M | +67.7% |
| FY 2018 | -$53.04M | -170.1% |
| FY 2017 |
Cardlytics, Inc. (CDLX) reported net income of -$104.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Cardlytics, Inc.'s net income declined from -$75.70M to -$104.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$19.64M |
| +74.1% |
| FY 2016 | -$75.70M | - |